Symbols / VCYT Stock $33.00 -2.11% Veracyte, Inc.

Healthcare • Diagnostics & Research • United States • NGM
VCYT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Stock Fundamentals
Scroll to Statements
Market Cap 2.62B Enterprise Value 2.31B Income 66.35M Sales 517.14M Book/sh 16.50 Cash/sh 5.20
Dividend Yield Payout 0.00% Employees 755 IPO P/E 40.24 Forward P/E 18.72
PEG P/S 5.07 P/B 2.00 P/C EV/EBITDA 27.31 EV/Sales 4.46
Quick Ratio 7.63 Current Ratio 8.15 Debt/Eq 3.03 LT Debt/Eq EPS (ttm) 0.82 EPS next Y 1.76
EPS Growth 7.12% Revenue Growth 18.50% Earnings 2026-05-05 ROA 2.91% ROE 5.34% ROIC
Gross Margin 72.17% Oper. Margin 17.50% Profit Margin 12.83% Shs Outstand 79.46M Shs Float 79.02M Short Float 8.87%
Short Ratio 5.89 Short Interest 52W High 50.71 52W Low 22.61 Beta 1.96 Avg Volume 905.72K
Volume 159.92K Target Price $46.55 Recom Buy Prev Close $33.71 Price $33.00 Change -2.11%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$46.55
Mean price target
2. Current target
$32.96
Latest analyst target
3. DCF / Fair value
$19.66
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$32.96
Low
$37.00
High
$53.00
Mean
$46.55

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-20 main Canaccord Genuity Hold → Hold $40
2026-04-13 init Jefferies — → Buy $45
2026-04-01 main Needham Buy → Buy $48
2026-03-30 main Guggenheim Buy → Buy $45
2026-03-06 main Morgan Stanley Underweight → Underweight $37
2026-02-26 main Needham Buy → Buy $48
2026-01-05 main Guggenheim Buy → Buy $50
2025-12-02 main Morgan Stanley Underweight → Underweight $48
2025-11-11 main Morgan Stanley Underweight → Underweight $40
2025-11-05 main UBS Buy → Buy $48
2025-11-05 main Canaccord Genuity Hold → Hold $43
2025-11-05 main Guggenheim Buy → Buy $45
2025-11-05 main Needham Buy → Buy $44
2025-10-20 init Canaccord Genuity — → Hold $40
2025-10-17 init Freedom Capital Markets — → Buy $45
2025-05-08 main UBS Buy → Buy $42
2025-05-08 main Needham Buy → Buy $41
2025-04-09 main Guggenheim Buy → Buy $37
2025-03-26 reit Stephens & Co. Overweight → Overweight $45
2025-03-20 init Craig-Hallum — → Buy $45
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-10 HAAS KEVIN RICHARD Officer 44,221 $0.00 $0
2026-03-06 FEBBO PHILLIP G Officer 36,181 $0.00 $0
2026-03-06 CHAMBERS REBECCA Chief Financial Officer 49,338 $0.00 $0
2026-03-06 MCGUIRE ANNIE General Counsel 59,206 $0.00 $0
2026-03-06 LEITE JOHN Officer 42,759 $0.00 $0
2026-03-06 STAPLEY MARC A Chief Executive Officer 92,099 $0.00 $0
2026-03-06 WYGANT JONATHAN Officer 10,525 $0.00 $0
2026-03-04 CHAMBERS REBECCA Chief Financial Officer 18,341 $35.55 $662,869
2026-03-04 MCGUIRE ANNIE General Counsel 6,658 $35.29 $236,725
2026-03-04 LEITE JOHN Officer 5,260 $35.19 $185,083
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
517.14
+16.01%
445.76
+23.46%
361.05
+21.76%
296.54
Operating Revenue
517.14
+16.01%
445.76
+23.46%
361.05
+21.76%
296.54
Cost Of Revenue
154.61
+4.74%
147.62
+12.37%
131.37
+8.70%
120.86
Reconciled Cost Of Revenue
135.69
+6.46%
127.46
+19.92%
106.28
+9.56%
97.01
Gross Profit
362.53
+21.60%
298.14
+29.81%
229.68
+30.74%
175.68
Operating Expense
284.25
+2.02%
278.63
+12.75%
247.13
+17.11%
211.02
Research And Development
70.81
+2.19%
69.29
+20.92%
57.30
+41.13%
40.60
Selling General And Administration
210.95
+2.38%
206.04
+9.76%
187.72
+9.93%
170.76
Selling And Marketing Expense
30.96
+11.46%
27.77
+4.39%
26.60
+5.15%
25.30
General And Administrative Expense
179.99
+0.97%
178.27
+10.65%
161.12
+10.76%
145.46
Salaries And Wages
152.12
+6.77%
142.48
+2.76%
138.66
+12.17%
123.61
Other Gand A
27.88
-22.13%
35.80
+59.37%
22.46
+2.82%
21.84
Total Expenses
438.86
+2.96%
426.25
+12.62%
378.50
+14.05%
331.88
Operating Income
78.28
+301.24%
19.51
+211.83%
-17.45
+50.63%
-35.34
Total Operating Income As Reported
57.78
+257.93%
16.14
+118.81%
-85.80
-108.84%
-41.08
EBITDA
89.62
+82.13%
49.20
+199.59%
-49.41
-379.65%
-10.30
Normalized EBITDA
112.86
+106.63%
54.62
+199.82%
18.22
+353.72%
-7.18
Reconciled Depreciation
21.41
-8.71%
23.46
-13.72%
27.19
+4.86%
25.93
EBIT
68.20
+164.90%
25.75
+133.61%
-76.60
-111.42%
-36.23
Total Unusual Items
-23.24
-329.34%
-5.41
+92.00%
-67.63
-2066.81%
-3.12
Total Unusual Items Excluding Goodwill
-23.24
-329.34%
-5.41
+92.00%
-67.63
-2066.81%
-3.12
Special Income Charges
-27.21
-707.99%
-3.37
+95.07%
-68.35
-1959.95%
-3.32
Impairment Of Capital Assets
3.37
-95.07%
68.35
+1959.95%
3.32
Write Off
20.50
+508.82%
3.37
-95.07%
68.35
+1959.95%
3.32
Net Income
66.35
+174.89%
24.14
+132.44%
-74.40
-103.51%
-36.56
Pretax Income
68.20
+164.92%
25.74
+133.60%
-76.61
-110.32%
-36.43
Net Non Operating Interest Income Expense
12.72
+14.09%
11.15
+52.16%
7.33
+313.13%
1.77
Interest Expense Non Operating
0.00
-50.00%
0.00
-86.67%
0.01
-92.42%
0.20
Net Interest Income
12.72
+14.09%
11.15
+52.16%
7.33
+313.13%
1.77
Interest Expense
0.00
-50.00%
0.00
-86.67%
0.01
-92.42%
0.20
Interest Income Non Operating
12.72
+14.08%
11.15
+51.88%
7.34
+272.41%
1.97
Interest Income
12.72
+14.08%
11.15
+51.88%
7.34
+272.41%
1.97
Other Income Expense
-22.80
-363.68%
-4.92
+92.60%
-66.50
-2224.19%
-2.86
Other Non Operating Income Expenses
0.44
-11.92%
0.49
-56.23%
1.13
+335.00%
0.26
Gain On Sale Of Security
3.97
+294.28%
-2.04
-382.85%
0.72
+267.01%
0.20
Gain On Sale Of Business
-6.71
Tax Provision
1.85
+15.07%
1.61
+172.74%
-2.21
-1760.15%
0.13
Tax Rate For Calcs
0.00
-56.72%
0.00
+116.45%
0.00
-86.28%
0.00
Tax Effect Of Unusual Items
-0.63
-85.82%
-0.34
+82.67%
-1.95
-197.37%
-0.66
Net Income Including Noncontrolling Interests
66.35
+174.89%
24.14
+132.44%
-74.40
-103.51%
-36.56
Net Income From Continuing Operation Net Minority Interest
66.35
+174.89%
24.14
+132.44%
-74.40
-103.51%
-36.56
Net Income From Continuing And Discontinued Operation
66.35
+174.89%
24.14
+132.44%
-74.40
-103.51%
-36.56
Net Income Continuous Operations
66.35
+174.89%
24.14
+132.44%
-74.40
-103.51%
-36.56
Normalized Income
88.97
+204.54%
29.21
+434.75%
-8.73
+74.40%
-34.09
Net Income Common Stockholders
66.35
+174.89%
24.14
+132.44%
-74.40
-103.51%
-36.56
Diluted EPS
0.82
+164.52%
0.31
+130.39%
-1.02
-100.00%
-0.51
Basic EPS
0.84
+162.50%
0.32
+131.37%
-1.02
-100.00%
-0.51
Basic Average Shares
78.58
+2.75%
76.48
+5.29%
72.64
+1.53%
71.55
Diluted Average Shares
80.57
+3.08%
78.16
+7.60%
72.64
+1.53%
71.55
Diluted NI Availto Com Stockholders
66.35
+174.89%
24.14
+132.44%
-74.40
-103.51%
-36.56
Amortization
2.49
-24.57%
3.30
+56.55%
2.11
+1.20%
2.08
Amortization Of Intangibles Income Statement
2.49
-24.57%
3.30
+56.55%
2.11
+1.20%
2.08
Depreciation Amortization Depletion Income Statement
2.49
-24.57%
3.30
+56.55%
2.11
+1.20%
2.08
Depreciation And Amortization In Income Statement
2.49
-24.57%
3.30
+56.55%
2.11
+1.20%
2.08
Depreciation Income Statement
3.49
+55.32%
2.25
Other Taxes
-0.50
+13.13%
-0.57
+76.43%
-2.42
Rent And Landing Fees
8.11
+39.48%
5.82
Rent Expense Supplemental
8.11
+39.48%
5.82
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,406.02
+8.15%
1,300.04
+16.60%
1,114.91
-3.59%
1,156.42
Current Assets
488.38
+31.19%
372.27
+30.34%
285.62
+14.88%
248.64
Cash Cash Equivalents And Short Term Investments
412.89
+42.65%
289.44
+33.72%
216.45
+21.02%
178.85
Cash And Cash Equivalents
362.58
+51.65%
239.09
+10.46%
216.45
+40.33%
154.25
Other Short Term Investments
50.31
-0.09%
50.35
0.00
-100.00%
24.61
Receivables
44.66
-4.01%
46.52
+15.22%
40.38
-8.28%
44.02
Accounts Receivable
44.66
-4.01%
46.52
+15.22%
40.38
-8.28%
44.02
Inventory
20.55
-5.54%
21.75
+34.86%
16.13
+12.83%
14.29
Raw Materials
20.55
+14.94%
17.88
+10.84%
16.13
+12.83%
14.29
Prepaid Assets
Other Current Assets
10.28
-29.35%
14.55
+14.93%
12.66
+10.39%
11.47
Total Non Current Assets
917.64
-1.09%
927.77
+11.88%
829.28
-8.65%
907.79
Net PPE
58.79
-17.36%
71.14
+130.52%
30.86
0.00%
30.86
Gross PPE
102.27
-7.47%
110.53
+73.46%
63.72
+12.10%
56.84
Accumulated Depreciation
-43.48
-10.39%
-39.39
-19.87%
-32.86
-26.47%
-25.98
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
16.58
-7.29%
17.88
+29.05%
13.86
+13.60%
12.20
Construction In Progress
0.00
-100.00%
0.11
-95.70%
2.46
+319.93%
0.59
Other Properties
73.32
-10.50%
81.92
+120.84%
37.09
+8.08%
34.32
Leases
12.38
+16.49%
10.62
+3.10%
10.31
+5.81%
9.74
Goodwill And Other Intangible Assets
856.30
+0.97%
848.10
+7.14%
791.58
-9.09%
870.76
Goodwill
767.15
+2.86%
745.80
+6.09%
702.98
+1.02%
695.89
Other Intangible Assets
89.15
-12.86%
102.30
+15.47%
88.59
-49.34%
174.87
Other Non Current Assets
2.55
-70.09%
8.53
+24.51%
6.85
+11.03%
6.17
Total Liabilities Net Minority Interest
96.44
-22.27%
124.07
+75.23%
70.80
-12.83%
81.22
Current Liabilities
59.94
-23.78%
78.63
+28.40%
61.24
-2.19%
62.61
Payables And Accrued Expenses
25.93
+18.61%
21.86
-12.33%
24.94
+30.93%
19.05
Payables
4.59
-46.80%
8.63
-33.29%
12.94
+8.66%
11.91
Accounts Payable
4.59
-46.80%
8.63
-33.29%
12.94
+8.66%
11.91
Current Accrued Expenses
21.34
+61.30%
13.23
+10.29%
12.00
+68.10%
7.14
Pensionand Other Post Retirement Benefit Plans Current
27.46
-10.25%
30.59
+15.76%
26.43
-13.73%
30.64
Current Debt And Capital Lease Obligation
4.05
-45.99%
7.50
+46.91%
5.11
+25.43%
4.07
Current Debt
Other Current Borrowings
Current Capital Lease Obligation
4.05
-45.99%
7.50
+46.91%
5.11
+25.43%
4.07
Current Deferred Liabilities
1.16
-30.66%
1.67
-16.68%
2.01
-23.15%
2.61
Current Deferred Revenue
1.16
-30.66%
1.67
-16.68%
2.01
-23.15%
2.61
Other Current Liabilities
1.33
-92.16%
17.00
+516.39%
2.76
-55.84%
6.25
Total Non Current Liabilities Net Minority Interest
36.51
-19.65%
45.44
+375.12%
9.56
-48.61%
18.61
Long Term Debt And Capital Lease Obligation
35.60
-17.66%
43.24
+474.58%
7.53
-29.33%
10.65
Long Term Capital Lease Obligation
35.60
-17.66%
43.24
+474.58%
7.53
-29.33%
10.65
Non Current Deferred Liabilities
0.65
-47.35%
1.23
+67.17%
0.73
-83.80%
4.53
Non Current Deferred Revenue
0.00
Non Current Deferred Taxes Liabilities
0.65
-47.35%
1.23
+67.17%
0.73
-83.80%
4.53
Other Non Current Liabilities
0.26
-73.56%
0.97
-25.46%
1.30
-61.97%
3.43
Stockholders Equity
1,309.58
+11.36%
1,175.97
+12.63%
1,044.10
-2.89%
1,075.20
Common Stock Equity
1,309.58
+11.36%
1,175.97
+12.63%
1,044.10
-2.89%
1,075.20
Capital Stock
0.08
+1.28%
0.08
+6.85%
0.07
+1.39%
0.07
Common Stock
0.08
+1.28%
0.08
+6.85%
0.07
+1.39%
0.07
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
79.36
+2.04%
77.77
+6.15%
73.26
+1.81%
71.96
Ordinary Shares Number
79.36
+2.04%
77.77
+6.15%
73.26
+1.81%
71.96
Additional Paid In Capital
1,695.34
+2.38%
1,655.96
+7.80%
1,536.17
+2.40%
1,500.19
Retained Earnings
-377.63
+14.94%
-443.98
+5.16%
-468.12
-18.90%
-393.72
Gains Losses Not Affecting Retained Earnings
-8.21
+77.25%
-36.09
-50.26%
-24.02
+23.38%
-31.35
Other Equity Adjustments
-8.21
+77.25%
-36.09
-50.26%
-24.02
+23.38%
-31.35
Total Equity Gross Minority Interest
1,309.58
+11.36%
1,175.97
+12.63%
1,044.10
-2.89%
1,075.20
Total Capitalization
1,309.58
+11.36%
1,175.97
+12.63%
1,044.10
-2.89%
1,075.20
Working Capital
428.44
+45.91%
293.63
+30.86%
224.38
+20.62%
186.02
Invested Capital
1,309.58
+11.36%
1,175.97
+12.63%
1,044.10
-2.89%
1,075.20
Total Debt
39.65
-21.84%
50.74
+301.72%
12.63
-14.19%
14.72
Capital Lease Obligations
39.65
-21.84%
50.74
+301.72%
12.63
-14.19%
14.72
Net Tangible Assets
453.27
+38.25%
327.87
+29.83%
252.53
+23.52%
204.44
Tangible Book Value
453.27
+38.25%
327.87
+29.83%
252.53
+23.52%
204.44
Other Inventories
3.87
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
136.31
+81.51%
75.10
+69.82%
44.22
+486.89%
7.54
Cash Flow From Continuing Operating Activities
136.31
+81.51%
75.10
+69.82%
44.22
+486.89%
7.54
Net Income From Continuing Operations
66.35
+174.89%
24.14
+132.44%
-74.40
-103.51%
-36.56
Depreciation Amortization Depletion
21.41
-8.71%
23.46
-13.72%
27.19
+4.86%
25.93
Depreciation And Amortization
21.41
-8.71%
23.46
-13.72%
27.19
+4.86%
25.93
Other Non Cash Items
-12.30
-272.76%
7.12
+681.39%
-1.23
-133.70%
3.63
Stock Based Compensation
43.60
+20.28%
36.25
+9.38%
33.14
+23.97%
26.73
Asset Impairment Charge
20.50
+508.82%
3.37
-95.07%
68.35
+1959.95%
3.32
Deferred Tax
-0.58
-149.36%
-0.23
+93.93%
-3.84
-2986.47%
0.13
Deferred Income Tax
-0.58
-149.36%
-0.23
+93.93%
-3.84
-2986.47%
0.13
Operating Gains Losses
2.89
+24.96%
2.31
+380.24%
-0.82
-213.32%
0.73
Net Foreign Currency Exchange Gain Loss
-3.83
-281.71%
2.11
+292.52%
-1.10
-309.96%
0.52
Gain Loss On Sale Of PPE
0.01
-92.57%
0.20
-25.46%
0.27
+31.55%
0.21
Change In Working Capital
-2.30
+89.02%
-20.96
-467.39%
-3.69
+77.44%
-16.38
Change In Receivables
-0.71
+88.95%
-6.41
-264.78%
3.89
+186.47%
-4.50
Changes In Account Receivables
-0.71
+88.95%
-6.41
-264.78%
3.89
+186.47%
-4.50
Change In Inventory
-2.86
+51.27%
-5.87
-246.58%
-1.69
+43.74%
-3.01
Change In Prepaid Assets
-2.05
-58.49%
-1.30
-182.97%
-0.46
-132.95%
1.39
Change In Payables And Accrued Expense
5.28
+790.71%
-0.76
+5.68%
-0.81
+78.50%
-3.77
Change In Accrued Expense
6.32
+78.37%
3.54
+623.82%
-0.68
+82.76%
-3.92
Change In Payable
-1.04
+75.87%
-4.30
-3112.69%
-0.13
-188.16%
0.15
Change In Account Payable
-1.04
+75.87%
-4.30
-3112.69%
-0.13
-188.16%
0.15
Change In Other Current Assets
0.53
+142.96%
-1.22
-321.38%
-0.29
+90.49%
-3.05
Change In Other Current Liabilities
-2.48
+54.13%
-5.41
-24.87%
-4.33
-25.58%
-3.45
Investing Cash Flow
-9.21
+83.64%
-56.27
-472.39%
15.11
+151.42%
-29.39
Cash Flow From Continuing Investing Activities
-9.21
+83.64%
-56.27
-472.39%
15.11
+151.42%
-29.39
Net PPE Purchase And Sale
-9.68
+14.26%
-11.29
-13.31%
-9.96
-16.52%
-8.55
Purchase Of PPE
-9.68
+14.26%
-11.29
-13.31%
-9.96
-16.52%
-8.55
Sale Of PPE
Capital Expenditure
-9.68
+14.26%
-11.29
-13.31%
-9.96
-16.52%
-8.55
Net Investment Purchase And Sale
3.31
+106.63%
-50.00
-299.42%
25.07
+220.32%
-20.84
Purchase Of Investment
-150.00
-200.00%
-50.00
-153.81%
-19.70
+41.23%
-33.52
Sale Of Investment
153.31
0.00
-100.00%
44.77
+253.07%
12.68
Net Business Purchase And Sale
-2.85
-156.76%
5.01
0.00
0.00
Purchase Of Business
-2.85
0.00
0.00
0.00
Gain Loss On Sale Of Business
6.71
0.00
0.00
Financing Cash Flow
-4.22
-186.09%
4.90
+72.86%
2.84
-18.80%
3.49
Cash Flow From Continuing Financing Activities
-4.22
-186.09%
4.90
+72.86%
2.84
-18.80%
3.49
Net Issuance Payments Of Debt
0.00
0.00
+100.00%
-1.28
Repayment Of Debt
0.00
0.00
+100.00%
-1.28
Long Term Debt Payments
0.00
0.00
+100.00%
-1.28
Net Long Term Debt Issuance
0.00
0.00
+100.00%
-1.28
Net Common Stock Issuance
0.00
0.00
Proceeds From Stock Option Exercised
14.08
-29.57%
19.99
+108.74%
9.58
+20.60%
7.94
Net Other Financing Charges
-18.30
-21.31%
-15.09
-123.84%
-6.74
-112.85%
-3.17
Changes In Cash
122.88
+417.92%
23.73
-61.84%
62.17
+438.66%
-18.36
Effect Of Exchange Rate Changes
0.72
+269.58%
-0.42
-360.12%
0.16
+127.53%
-0.59
Beginning Cash Position
240.63
+10.72%
217.33
+40.22%
155.00
-10.89%
173.95
End Cash Position
364.23
+51.36%
240.63
+10.72%
217.33
+40.22%
155.00
Free Cash Flow
126.63
+98.45%
63.81
+86.24%
34.26
+3478.80%
-1.01
Interest Paid Supplemental Data
0.00
0.00
-100.00%
0.01
Income Tax Paid Supplemental Data
2.24
+31.76%
1.70
+197.72%
0.57
Amortization Of Securities
-3.27
-823.73%
-0.35
+24.36%
-0.47
Common Stock Issuance
0.00
0.00
Issuance Of Capital Stock
0.00
0.00
Sale Of Business
0.00
-100.00%
5.01
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category